IMNN (Imunon Inc) Net earnings per share for the last 12 months

Official company branding of Celsion Corporation (IMNN)

The 12-month net income per share trend for Imunon, Inc. (IMNN) highlights the implementation of laboratory automation for molecule analysis. The business relies on the development of DNA vaccines against ovarian cancer and the licensing of Theraiva. Demand for oncology research remains stable, ensuring resilience to macroeconomic shocks, while the value of -3.31 serves as the current reading for this fundamental metric.

IMNN (Imunon, Inc.) Net earnings per share for the last four quarters history from 04/28/2023 to 11/15/2026

IMNN (imunon.com): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Imunon Inc|IMNN - Broker Consensus Forecast
- business market valuation indicators:
Market Valuation IMNN|IMNN - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Book Value per Share Imunon|IMNN - Book Valuation of Business|Market Value to Book Value Ratio imunon.com|IMNN - Total Business Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Imunon, Inc.|IMNN - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Imunon Inc|IMNN - Company Total Debt Obligations|Debts to Book Capitalization Imunon|IMNN - Long-Term Debt Volume|Company Short-Term Debt Imunon|Quick Liquidity imunon.com
- net income and valuation multiples indicators:
IMNN - Company Profit|Expected Profit Imunon, Inc.|IMNN - Price to Earnings Multiple|Forward P/E Multiple Imunon Inc|IMNN - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Imunon|IMNN - Operating profit before amortization|Net earnings per share (EPS TTM) Imunon|IMNN - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth imunon.com|IMNN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Imunon, Inc.
- total revenue and sales volume data:
IMNN - Company Sales|Company Future Sales Volume Imunon, Inc.|IMNN - P/S Multiple|Price-to-Projected Revenue Ratio Imunon|IMNN - Sales Growth YoY (Last 12 Months)
Fundamental company analysis:Imunon, Inc. (IMNN)
Manufactured products of Imunon, Inc.

This indicator reflects the portion of net income attributable to a single common share over the past year. The calculation is based on dividing total income minus all expenses by the total number of shares outstanding. By analyzing the net income per share over 12 months, an investor assesses the real efficiency of capital generation. For Imunon, Inc. (IMNN), this trend confirms financial stability during the implementation of sustainable production standards for DNA-based drugs. Growth in net income per share over 12 months signals the successful optimization of biotechnological laboratories.

Competitors of Imunon, Inc.

TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics AG) - Earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx (WGS)|RARE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics Inc)|Earnings per share for the trailing year SRPT|twistbioscience.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TXG (10x Genomics, Inc.)|NTLA: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months STOK (Stoke Therapeutics, Inc.)|Net earnings per share for the last 12 months BLFS|Net earnings per one share for the last twelve months Wave Pharma WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION - Net earnings per one share for the last twelve months|Prime Medicine - Net earnings per share for the last 12 months|Taysha Gene Therapies Inc (TSHA) - Net earnings per one share for the last twelve months|uniqure.com - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pacific Biosciences of California, Inc. PACB|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last four quarters Design Pharma|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|Net earnings per one share for the last twelve months Codexis CDXS|Earnings per share for the last twelve months Sangamo BioSciences (SGMO)|Net earnings per share (EPS TTM) Nautilus Biotechnology Inc (NAUT)|Net earnings per share (EPS TTM) MGX (Metagenomi Inc.)|Precision BioSciences - Earnings per share for the last twelve months|generationbio.com - Net earnings per share (EPS TTM)|BOLD: Earnings per share for the last twelve months|XCUR (Exicure Corp) - Net earnings per share for the last 12 months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)